Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Pentamidine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Luteolin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 4 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Myricetin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021 5 0
SARS-CoV-2-IN-1 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/09/2020 3 0